what is immunotherapy for pancreatic cancer?

Q: what is immunotherapy for pancreatic cancer?

In short Immunotherapy uses the body's immune system to fight pancreatic cancer [2]. It includes treatments like vaccines, cell therapies, and drugs that help immune cells work better [4]. However, it is currently very difficult to treat pancreatic cancer this way because the tumor blocks the immune system [3]. The details Immunotherapy is considered a new pillar of treatment alongside surgery, radiation, and chemotherapy [4]. Types of immunotherapy include immune checkpoint inhibitors, cancer vaccines, CAR T-cell therapy, and dendritic cell vaccines [2]. In patients who have had surgery, dendritic cell immunotherapy helped 68% of patients stay free of cancer recurrence for two years [5]. For advanced or metastatic pancreatic cancer, immunotherapy has shown limited success so far [5]. The main challenge is the "immunosuppressive microenvironment," which means the tumor creates a shield that stops immune cells from attacking it [3]. What to know Most current immunotherapies are not yet highly effective for advanced pancreatic cancer on their own [3]. Researchers are studying ways to break through the tumor's shield to make these treatments work better [2]. These findings come from research studies and do not replace advice from your doctor.

Question

Accepted Answer

In short

Immunotherapy uses the body's immune system to fight pancreatic cancer [2]. It includes treatments like vaccines, cell therapies, and drugs that help immune cells work better [4]. However, it is currently very difficult to treat pancreatic cancer this way because the tumor blocks the immune system [3].

The details

Immunotherapy is considered a new pillar of treatment alongside surgery, radiation, and chemotherapy [4].

Types of immunotherapy include immune checkpoint inhibitors, cancer vaccines, CAR T-cell therapy, and dendritic cell vaccines [2].

In patients who have had surgery, dendritic cell immunotherapy helped 68% of patients stay free of cancer recurrence for two years [5].

For advanced or metastatic pancreatic cancer, immunotherapy has shown limited success so far [5].

The main challenge is the "immunosuppressive microenvironment," which means the tumor creates a shield that stops immune cells from attacking it [3].

What to know

Most current immunotherapies are not yet highly effective for advanced pancreatic cancer on their own [3]. Researchers are studying ways to break through the tumor's shield to make these treatments work better [2]. These findings come from research studies and do not replace advice from your doctor.